Abstract: A container for housing a welding wire that includes an outer sleeve and at least one support member. The outer sleeve of the container may define an interior cavity. The outer sleeve of the container may be in the shape of an irregular octagonal prism. The at least one support member may be disposed within the interior cavity of the outer sleeve. The at least one support member may also extend vertically through the interior cavity of the outer sleeve. The at least one support member may be in the shape of a trapezoidal prism. With the at least one support member disposed within the interior cavity of the outer sleeve, the at least one support member and the outer sleeve collectively define a region of the interior cavity of the first sleeve that has a regular octagonal shaped cross-section.

Abstract: A system and method for reinforcing a sidewall of a carrier with an insert is disclosed. The insert includes a plate having a front face and a rear face opposite the front face, the plate defining an opening extending between the front face and the rear face. An oblique tab extends from the front face in a first direction, and a flange extends from the plate in a second direction.

Abstract: Improved methods and intermediates thereof for preparing carbamoyloxy methyl triazole cyclohexyl acid compounds are described. These compounds are useful as LPA antagonists. Formula (I).

Abstract: The invention provides a composition (e.g., pharmaceutical composition) comprising a combination of two or more phages, wherein the phages are two or more of: (a) phage D29; (b) phage Adephagia?41?43; (c) phage Fionnbharth?47; (d) phage Fred313cpm-1; and (e) phage MuddyHRMN0052-1; and a pharmaceutically acceptable carrier. The invention provides a method of treating, reducing, or preventing a disease caused by Mycobacterium tuberculosis in a mammal comprising administering a pharmaceutical composition comprising a combination of two or more phages wherein the phages are two or more of: (a) phage D29; (b) phage Adephagia?41?43; (c) phage Fionnbharth?47; (d) phage Fred313cpm-1; and (e) phage MuddyHRMN0052-1; and a pharmaceutically acceptable carrier. The composition can be administered alone or in combination with one or more antibiotics, wherein the length of treatment is reduced as compared to the length of treatment with one or more antibiotics alone.

Abstract: The invention generally relates to a process for preparing compounds, including Compound of Formula (I), useful as key intermediates in the preparation of compounds having ROR?t antagonist properties.

Abstract: A stackable pallet display system includes a tray portion having a rectangular bottom wall, corner posts extending upward from corners of the tray portion and an interior divider panel extending upward from the tray portion. The tray, corner posts and interior divider wall of the system can be folded from blanks of material.

Abstract: The invention generally relates to a process for preparing compounds, including Compound of Formula (I), useful as key intermediates in the preparation of compounds having ROR?t antagonist properties.

Abstract: A stackable pallet display system includes a tray portion having a rectangular bottom wall, corner posts extending upward from corners of the tray portion and an interior divider panel extending upward from the tray portion. The tray, corner posts and interior divider wall of the system can be folded from blanks of material.

Abstract: The present invention is in the field of fluids and the like comprising magnetic particles, such as ferromagnetic particles, anti-ferromagnetic particles, ferrimagnetic particles, synthetic magnetic particles, paramagnetic particles, superparamagnetic particles, such as magnetic fluids, a method of stabilizing magnetic particles, use of these fluids and functionalized particles. Such fluids have a large variety of applications, such as sealants, as a sensor, in biomedics, etc. The present invention is further directed to a method of obtaining a catalyst for use in the depolymerisation of polymers into oligomers and monomer.

Abstract: A stackable pallet display system includes a tray portion having a rectangular bottom wall, corner posts extending upward from corners of the tray portion and an interior divider panel extending upward from the tray portion. The tray, corner posts and interior divider wall of the system can be folded from blanks of material.

Abstract: The present invention is in the field of fluids and the like comprising magnetic particles, such as ferromagnetic particles, anti-ferromagnetic particles, ferrimagnetic particles, synthetic magnetic particles, paramagnetic particles, superparamagnetic particles, such as magnetic fluids, a method of stabilizing magnetic particles, use of these fluids and functionalized particles. Such fluids have a large variety of applications, such as sealants, as a sensor, in biomedics, etc.

Abstract: A stackable pallet display system includes a tray portion having a rectangular bottom wall, corner posts extending upward from corners of the tray portion and an interior divider panel extending upward from the tray portion. The tray, corner posts and interior divider wall of the system can be folded from blanks of material.

Abstract: The present invention is in the field of fluids and the like comprising magnetic particles, such as ferromagnetic particles, anti-ferromagnetic particles, ferrimagnetic particles, synthetic magnetic particles, paramagnetic particles, superparamagnetic particles, such as magnetic fluids, a method of stabilizing magnetic particles, use of these fluids and functionalized particles. Such fluids have a large variety of applications, such as sealants, as a sensor, in biomedics, etc.

Abstract: A stackable pallet display system includes a tray portion having a rectangular bottom wall, corner posts extending upward from corners of the tray portion and an interior divider panel extending upward from the tray portion. The tray, corner posts and interior divider wall of the system can be folded from blanks of material.

Abstract: A method of degrading a polymer into oligomers and/or monomers in a solvent, using a catalyst, and a functionalized magnetic particle comprising a catalyst being capable of degrading the polymer into oligomers and/or monomers. The present method and particle provide a high selectivity and a high conversion ratio.

Abstract: An improved process for making a compound B of the structure wherein n, R1, R2, and R3 are as defined in the specification. Compound B can be used to make tubulysin analogs that are, in turn, useful as anti-cancer agents, particularly when deployed in an antibody-drug conjugate.

Abstract: An improved process for making a compound B of the structure wherein n, R1, R2, and R3 are as defined in the specification. Compound B can be used to make tubulysin analogs that are, in turn, useful as anti-cancer agents, particularly when deployed in an antibody-drug conjugate.